ABSTRACT Our previous transcriptional profiling study using a turkey skeletal muscle-specific oligonucleotide microarray revealed over 3,000 genes that were differentially expressed at 3 critical stages of muscle development: 18 d embryonic, 1 d posthatch, and 16 wk of age. The genes versican, matrix Gla protein (MGP), and death-associated protein (DAP) were selected to study for their potential effects on muscle satellite cell proliferation and differentiation, as their functions in other tissues are suggestive of possible key roles in the regulation of myogenesis and they are differentially expressed throughout muscle development in the turkey. Using small interfering RNA to knockdown the expression of these genes during proliferation and differentiation, each of the genes was found to differentially affect proliferation and differentiation. Versican and MGP predominantly affected proliferation with line effects, but later stages of differentiation were affected by the knockdown of versican and MGP. The underexpression of DAP inhibited myotube formation, which is a necessary stage in the development of muscle fibers. Without myotube development, muscle fiber formation will be inhibited or abolished. This is the first report that these genes with no previously documented functions with regard to muscle development play a critical role in muscle cell proliferation and differentiation.
INTRODUCTION
Early embryonic development of skeletal muscle results from the proliferation, differentiation, and fusion of embryonic myoblasts. The process of muscle fiber formation is nearly complete at birth or hatch (Smith, 1963) . Subsequently, postnatal or posthatch muscle growth largely results from the activity of myogenic satellite cells which are located between the basement membrane and plasmalemma of muscle fibers (Mauro, 1961) . Satellite cells proliferate, differentiate, and fuse with adjacent fibers, providing muscle cells with an increased number of nuclei. The increased number of nuclei leads, in part, to further muscle growth by hypertrophy.
Although the developmental events leading to the formation of muscle fibers are well understood, the identities and functional roles of the genes that influence the process of muscle growth and development remain to be elucidated. Genetic selection for increased muscle growth alters satellite cell activity. Velleman et al. (2000) showed that satellite cell proliferation and differentiation was increased in vitro in a turkey line (F) selected only for increased 16-wk BW compared with a nonselected randombred control line (RBC2) from which the F line was developed. In support of these results, muscle fiber width in the pectoralis major muscle was increased in the F line compared with the RBC2 line . Further studies using a single gene approach have shown that expression of extracellular matrix heparan sulfate proteoglycans (Liu et al., 2002) and fibroblast growth factor 2 (Liu et al., 2003) in the pectoralis major muscle was altered by growth rate.
To identify novel genes that may be involved in myogenesis, a complete muscle transcriptome analysis was performed using a skeletal muscle-focused microarray. The Turkey Skeletal Muscle Long Oligonucleotide (TSKMLO) array was constructed based on sequences Versican, matrix Gla protein, and death-associated protein expression affect muscle satellite cell proliferation and differentiation 1 S. G. Velleman ,* 2 K. R. B. Sporer , † C. W. Ernst , ‡ K. M. Reed , § and G. M. Strasburg † from pectoralis major muscle cDNA libraries obtained from the RBC2 and F lines at 3 developmental stages (Reed et al., 2008; Sporer et al., 2011a) . The developmental stages were 18 d embryo and 1 d and 16 wk posthatch. These stages were selected as they represent the phases of hyperplasia, hypertrophy, and market age, respectively. Sporer et al. (2011b) reported that over 3,000 genes were differentially expressed (false discovery rate; FDR <0.001) as a function of developmental stage, but only 16 were differentially expressed (FDR <0.10) by overall effect of the F and RBC2 lines with some being known genes, whereas others are as yet unannotated. Three genes observed to be differentially expressed during turkey muscle development (Sporer et al., 2011b) were identified for further investigation. Their functions in other tissues are suggestive of key roles in regulating muscle cell proliferation and differentiation. The differentially expressed genes selected were versican, matrix Gla protein (MGP), and deathassociated protein (DAP). Versican is a large chondroitin sulfate proteoglycan which was initially identified in cultured fibroblasts (Zimmermann and Ruoslahti, 1989) . The protein contains 2 globular domains, the N-terminal (G1 domain) and the C-terminal (G3 domain), separated by a glycosaminoglycan attachment region. The G3 domain of versican contains 2 epidermal growth factor-like repeats which have been shown to enhance cell proliferation (Zhang et al., 1998) . In the microarray experiments conducted by Sporer et al. (2011b) , versican expression was maximal in breast muscle from 18-d-old embryos, the stage at which muscle is still undergoing hyperplasia. Interestingly, versican expression decreased by 80 to 90% by 1 d posthatch when hypertrophy was occurring and declined further in the 16-wk posthatch muscle samples. Moreover, versican expression was significantly higher in the breast muscles from the RBC2 line compared with that of the F line at 1 d posthatch.
Matrix Gla protein is a vitamin K-dependent protein that affects differentiation by directly interacting with bone morphogenetic protein (BMP-2) in mesenchymal and marrow stromal cells (Wallin et al., 2000; Boström et al., 2001; Zebboudj et al., 2002) . Due to the sequence homology between MGP and bone Gla protein (BGP), it is hypothesized that MGP and BGP arose by gene duplication of a common ancestral sequence (Price and Williamson, 1985) . In the authors' microarray experiments, MGP expression increased dramatically in 1-d posthatch muscle compared with the 18-d embryonic muscle; MGP mRNA abundance increased approximately 55-fold for the F line and 80-fold for the RBC2 line (Sporer et al., 2011b) .
Death-associated protein is a highly conserved proline-rich phosphoprotein which was first identified in HeLa cells treated with an antisense cDNA library and interferon-γ (Deiss et al., 1995) . Recent studies have shown that DAP is a substrate of mTOR (Koren et al., 2010) which is a primary intracellular pathway controlling muscle hypertrophy (Bodine et al., 2001 ). Deathassociated protein expression in the turkey was highest in the 18-d embryonic muscle samples and expression declined by 35% and 60% in the RBC2 and F lines at 1 d posthatch, respectively. Expression continued to decrease significantly in the muscle samples at 16 wk of age, decreasing by approximately 80% in both lines compared with that of the 18-d embryo.
The objective of the current study was to determine the effect of versican, MGP, and DAP expression on myogenic satellite cell proliferation and differentiation in the F and RBC2 lines. Versican, MGP, and DAP mRNA expression was measured during proliferation and differentiation. Small interfering RNA (siRNA) knockdown experiments were conducted to characterize the significance of these genes during satellite cell proliferation and differentiation. The results from the current study suggest that all 3 genes play differential roles in the proliferation and differentiation processes.
MATERIALS AND METHODS

Cell Culture
Satellite cells isolated from the pectoralis major muscle of 7-wk-old male RBC2 and F line turkeys, and previously characterized for proliferation and differentiation characteristics were used in the current study (Velleman et al., 2000) .
Total RNA Extraction, cDNA Synthesis, and Real-Time Quantitative PCR Every 24 h beginning at 48 h of proliferation through 72 h of differentiation, F and RBC2 cell cultures were removed from the incubator, medium removed, airdried, and then stored at −70°C. Total cellular RNA was extracted using TriReagent (Molecular Research Center Inc., Cincinnati, OH) according to the manufacturer's recommended protocol. Complementary DNA was synthesized from 1 μg of RNA using Moloney murine leukemia virus reverse transcriptase (M-MLV, Promega). In brief, the RNA-primer mix consisting of 1 μL of 50 μM oligo d(T) 20 (Operon, Huntsville, AL), 1 μg of total RNA, and nuclease-free water up to 13.5 μL was heated at 70°C for 5 min. The mixture was cooled down on ice for at least 2 min. To the cooled RNA-primer mix, 5 μL of 5× first-strand buffer (250 mM Tris HCl pH 8.3, 375 mM KCl, 15 mM MgCl 2 , and 50 mM dithiothretiol; Promega), 1 μL 10 mM deoxynucleoside triphosphate mix (Promega), 0.25 μL RNasin (40U/ μL; Promega), 1 μL M-MLV (200U/μL), and nucleasefree water up to 11.5 μL were added. The reaction mixture was incubated at 55°C for 60 min and then heated at 85°C for 5 min to stop the reaction.
The real-time (RT) quantitative PCR was performed using a DNA Engine Opticon 3 real-time system (Biorad, Hercules, CA). A non-reverse-transcribed control RNA sample was used with each RT-PCR experiment to check for the absence of genomic or plasmid DNA contamination. Primer sequences are listed in Table 1 . All primers were purchased from Operon. The RT-PCR was performed using DyNAmo Hot Start SYBR Green qPCR kit (Finnzymes, Ipswich, MA). The PCR reaction consisted of 2 μL of the cDNA, 10 μL of 2× master mix, and 1 μL containing the forward and reverse primers (final concentration 0.25 μM for each primer), and brought to a final volume of 20 μL with nuclease-free water. The cycling parameters were denaturation 95°C for 15 min followed by amplification and quantitation (35 cycles of 94°C for 30 s, 58°C for 30 s except for DAP at 55°C, and 72°C for 30 s, and final extension at 72°C for 5 min). The melting curve program was 52°C to 95°C, 0.2°C/read, and a 1-s hold. The final PCR products were analyzed on a 1% agarose gel to check for amplification specificity. Standard curves were performed for every experiment with serial dilutions of purified PCR products from each gene. The PCR products were purified by agarose gel electrophoresis using a QIAquick gel extraction kit (Qiagen). All of the sample concentrations fell within the values of the standard curves. The amount of sample cDNA for each gene was interpolated from the corresponding standard curve. The expression of each gene was normalized to the expression of GAPDH and reported as arbitrary units. The arbitrary unit is a relative unit of measurement to show the amount of the targeted gene relative to the standard curve. The GAPDH Ct number remained constant throughout the duration of the assay.
Small Interfering RNA
The siRNA sequences targeting DAP, MGP, and versican were designed using Invitrogen's BLOCKiT RNAi designer (https://rnaidesigner.invitrogen. com/sirna). The primer sequences targeting DAP corresponding to the coding region 167 to 85 were 5′-GGAUGAUCAAGACUGGGAATT-3′ (sense) and 5′-UUCCCAGUCUUGAUCAUCC-3′ (antisense). The primer sequences targeting MGP corresponding to the coding region 348 to 366 were 5′-GGACUUCCACCU-GUGUGAA-3′ (sense) and UUCACACAGGUGGAA-GUCC-3′ (antisense). The primer sequences targeting versican corresponding to the coding region 7278 to 7296 were 5′-GCUCAUCAGUGAUCCAUUA-3′ (sense) and 5′-UAAUGGAUCACUGAUGAGC-3′ (antisense). The siRNA were purchased from Invitrogen in the desalted, pre-annealed duplex form. The transfection of the siRNA into the F and RBC2 satellite cells were done using Lipofectamine 2000 (Invitrogen) according to the manufacturer's recommended conditions.
Proliferation Assay
The proliferation assay was performed as previously described by Velleman et al. (2006) . In brief, 24 h after plating the cells in 24-well gelatin-coated cell culture plates and in antibiotic-free plating media, the F and RBC2 satellite cell cultures were transfected cells with the appropriate siRNA or mock-transfected to a final concentration of 20 pM of each siRNA and 1.5 μL lipofectamine 2000 (Invitrogen) contained in 100 μL Opti-MEM I Reduced Serum medium (Invitrogen) per well. The transfection mixture was added to the cells and incubated for 5 h at 37°C in a 95% air/5% CO 2 incubator. After incubation, the medium was replaced with growth medium containing McCoy's 5A (SigmaAldrich, St. Louis, MO) containing 10% chicken serum (Gemini BioProducts, West Sacramento, CA) and 5% horse serum (Gemini BioProducts) with 0.1% antibiotic/antimycotic (Gemini BioProducts). Every 24 h after the transfection for 72 h, plates were removed, wells were rinsed with PBS, and samples were stored at −70°C until assayed. Proliferation was measured by the DNA content in each well as described by McFarland et al. (1995) . The DNA concentration was measured using Hoechst 33258 fluorochrome (Sigma-Aldrich) on a Fluoroskan Ascent FL plate reader (ThermoElectron Co., Waltham, MA) using double-stranded calf thymus DNA as the standard.
Differentiation Assay
The differentiation assay was adapted from Florini (1989) and Yun et al. (1997) with the following modifications. The siRNA transfection was performed as described in the proliferation assay. The growth medium was changed every 24 h until the cells reached 60 to 65% confluency. Differentiation was induced by changing the medium to Dulbecco's modified eagle medium (DMEM; Sigma-Aldrich) containing 3% horse serum, 0.1 mg/mL porcine gelatin (Sigma-Aldrich), and 1.0 mg/mL BSA (Sigma-Aldrich) with 10 μg/mL gentamicin (Invitrogen) and 0.1% antibiotic/antimycotic. The differentiation medium was changed daily. Every 24 h during the differentiation period the plates were removed, washed with PBS, and stored at −70°C until analysis. Differentiation was determined by measuring the muscle-specific creatine kinase levels as modified from the method of Yun et al. (1997) . At the time of assay, all plates were thawed at room temperature for 10 min. During this time, a standard curve of creatine phosphokinase (Sigma-Aldrich) was prepared in a 24-well plate to use as a standard with a range of 0 to 60 U per well brought to final volume of 1.2 mL in creatine kinase assay buffer [20 mM glucose (Fisher Scientific, Pittsburgh, PA), 10 mM Mg acetate (Fisher Scientific), 1.0 mM adenosine diphosphate (Sigma-Aldrich), 10 mM adenosine monophosphate (Sigma-Aldrich), 20 mM phosphocreatine (Calbiochem, LaJolla, CA), 0.5 U/mL hexokinase (Worthington Biochemical, Lakewood, NJ), 1 U/mL glucose-6-PO 4 dehydrogenase (Worthington Biochemical), 0.4 mM thio-nicotinamide adenine dinucleotide (OYC Americas, Andover, MA), and 1 mg/mL BSA prepared in 0.1 M glycylglycine (Sigma-Aldrich), pH 7.5]. To the experimental plates 1.2 mL of creatine kinase assay buffer was added to each well. The plates were wrapped in aluminum foil and incubated at room temperature for 10 min. The rate of thio-nicotinamide adenine dinucleotide reduction was determined by absorbance measurements at 5-min intervals for 30 min with a BioTek ELx800 plate reader (Biotek, Winooski, VT) with a wavelength setting of 405 nm.
Measurement of Myotube Diameter
At 72 h of differentiation, myotube diameter was measured for each of the gene treatments in both the RBC2 and F lines. Cultures were viewed with an Olympus XI 70 microscope (Olympus America Inc., Melville, NY) and images digitally recorded with a QImaging camera system (Burnaby, BC, Canada). Diameter measurements for 20 myotubes per sample were determined using Image Pro Software (Media Cybernectics, Silver Spring, MD).
Statistical Analysis
All cell experiments were independently repeated at least 3 times. Within each experiment for proliferation, 4 replicates of the control and siRNA knockdown for each gene were run and 3 replicates for differentiation. For the RT-PCR, 3 replicates of the control and siR-NA knockdown were performed. All statistical analyses were performed using Statistical Analysis System for Windows V.9 (2004: SAS Institute Inc., Cary, NC). For the expression analysis, the data from each trial were used to generate a mean and the standard error of the mean (SEM) within a time. Line means were compared using Student's t-test. Data are graphed as the mean ± SEM. The cell proliferation and differentiation assay data were analyzed within each time period using a general linear model (Proc GLM, SAS, Version 9, 2004) that included line (1 degree of freedom; df), gene treatment (siRNA knockdown; 1 df), line by treatment interaction (1 df), and error.
RESULTS
Versican, MGP, and DAP Exhibit Temporal and Line Differences in Expression During Turkey Satellite Cell Proliferation and Differentiation
Expression of versican, MGP, and DAP was measured by RT-PCR during both proliferation (48, 72, and 96 h of proliferation) and differentiation (24, 48, and 72 h of differentiation) of the RBC2 and F line satellite cells. For all 3 genes, differences in expression were observed between the RBC2 and F lines, suggesting that the expression of these genes was influenced by differences in growth characteristics of the satellite cells. Versican expression in the F line was significantly higher than the RBC2 line at 48 and 72 h of proliferation at which time versican expression was at its highest level ( Figure 1A ). Satellite cells from the RBC2 line exhibited maximal versican expression at 96 h of proliferation. In contrast to the early expression of versican, MGP mRNA levels increased slowly during proliferation and peaked in both the RBC2 and F line cells during differentiation ( Figure 1B ). Satellite cells from the RBC2 line expressed significantly higher levels of MGP mRNA compared with the F line throughout all stages assayed (P < 0.05). Although DAP had significant expression differences at 72 and 96 h of proliferation and 24 and 48 h of differentiation (P < 0.05), large expression differences between the RBC2 and F lines were observed only at 72 h of proliferation and 24 h of differentiation ( Figure 1C ). At both 72 h of proliferation and 24 h of differentiation, the F line expressed higher levels of DAP (P < 0.05).
Knockdown of Versican, MGP, and DAP Alter the Proliferation and Differentiation Characteristics of Satellite Cells
The expression of versican, MGP, and DAP was reduced using a siRNA targeting each gene. As shown in Figure 2A ,B,C, the expression of the respective genes was knocked down at least 50% at 72 h following the transfection. The effect of reduced gene expression was assayed during proliferation and differentiation of the RBC2 and F line satellite cells.
During proliferation, knockdown of versican expression resulted in both line and treatment effects ( Figure  3A) . At 24 h following the transfection, cells from the F line exhibited increased proliferation which continued through 72 h of proliferation. The RBC2 cells showed a similar effect to the reduction in versican although this observation was only significant at 72 h of proliferation. Line differences in cell proliferation between the RBC2 and F line were observed beginning at 0 h when differentiation was initiated and remained for the 72 h duration of the study.
Reduction in the expression of MGP by siRNA knockdown had no effect on proliferation in the RBC2 line ( Figure 3B ). In contrast, the F line control cells proliferation rate was higher than the MGP knockdown cells beginning at 24 h following the transfection and throughout the duration of the proliferation period. In addition to treatment effects, there were significant line effects from 0 to 72 h: cells from the F line showed higher proliferation rates than cells from the RBC2 line.
Knockdown of DAP expression decreased proliferation in both the RBC2 and F lines beginning 24 h after the transfection, and by 72 h of proliferation, the reduction was 40 to 50% ( Figure 3C ). Although both lines exhibited similar treatment effects on proliferation, there were line differences between the RBC2 and F lines, with the RBC2 line having lower proliferation.
The effects of versican, MGP, and DAP knockdowns on satellite cell morphology were evaluated by light microscopy. Photographic images of the F line ( Figure  4A ,C,E, and G) and RBC2 line satellite cells ( Figure  4B ,D,F, and H) at 72 h of proliferation were taken. For both lines, the control cells, and the versican-, and MGP-treated cells exhibited an elliptical phenotype which is characteristic of satellite cells attached to the substrate. In contrast, cells treated with the siRNA against DAP appeared more rounded in structure than the controls in both lines which is often characteristic of apoptotic cells. (Figure 4G and H) .
The effects of versican, MGP, and DAP expression on differentiation of the F and RBC2 line satellite cells into multinucleated myotubes were measured in the corresponding siRNA-treated cells ( Figure 5A to C). Beginning at 48 h, F-line cells with the versican siRNA had increased differentiation compared with the control cells, whereas there was no treatment effect in the RBC2-line cells at 48 h. At 72 h of differentiation, there were treatment effects in both the F-and RBC2-line cells with differentiation increasing by more than 30% in concert with the knockdown of versican ( Figure 5A ). The reduction in MGP expression at 72 h resulted in increased differentiation in both the F and RBC2 lines ( Figure 5B ), whereas at 48 h there were line differences in differentiation and a treatment effect only in the F line. Knockdown of DAP in both the F and RBC2 lines dramatically inhibited differentiation ( Figure 5C ). A treatment effect was present at 0 h of differentiation. There were line differences in differentiation that were significant beginning at 48 h with the F-line control cultures differentiating at a faster rate than the RBC2 control cells.
During differentiation in vitro, satellite cells will form long multinucleated myotubes. In agreement with the biochemical data measuring differentiation, the myotube width at 72 h of differentiation for the versicantreated cells was 42.95 ± 4.03 and 39.53 ± 2.99 μm, respectively ( Figure 6C and D) compared with the con- trol cells which measured 33.53 ± 2.16 μm for the RBC2 and 34.23 ± 2.54 μm for the F line ( Figure 6A and B) . Morphologically, no measurable difference in myotube width was present in the MGP-transfected cell cultures at 72 h of differentiation in the RBC2 and F lines, 32.35 ± 2.32 μm and 32.38 ± 2.29 μm, respectively ( Figure   6E and F). The DAP siRNA-transfected cells exhibited the most dramatic changes. As suggested by the differentiation assay data, photomicrographs showed that myotube formation was strongly inhibited by reducing DAP expression in both the F-and RBC2-line satellite cell cultures ( Figure 6G and H) . The myotubes in 
DISCUSSION
Precise temporal expression of genes is required for skeletal muscle growth and development. Gene expression experiments comparing breast muscle profiles between the turkey F and RBC2 lines at 3 developmental stages (18-d embryo, 1-d posthatch poult, and 16-wk posthatch turkey) was used as the basis for the selection of genes in the current study. Genes exhibiting changes in developmental expression fell into several categories, including extracellular matrix genes, cell death/apoptosis genes, calcium signaling/muscle function genes, and genes of unknown or with an uncertain function. In the present study, 3 genes with significant changes in expression between developmental stages and with no well-established function in myogenesis were selected for further study of their roles in the proliferation and differentiation of satellite cells. The genes ultimately selected for further study were versican, MGP, and DAP.
The myogenic process is partially regulated through the interactions of muscle cells with their extrinsic or extracellular matrix (ECM) environment. The ECM is an organized structure located outside the cell that is composed of proteins and polysaccharides synthesized by the cell (Scott, 1995) . Proteoglycans, one macromolecular component of the extracellular matrix, contain a central core protein to which one or more glycosaminoglycan chains are attached. Typical glycosaminoglycan chains attached to the core protein include chondroitin sulfate, heparan sulfate, dermatan sulfate, and keratan sulfate. During muscle development, proteoglycan expression is dynamic. In early stages of the development, the matrix contains the large chondroitin sulfate proteoglycan, versican, which is then replaced before birth or hatching to growth-factor-regulating proteoglycans (Young et al., 1990; Fernandez et al., 1991; Velleman et al., 1999) . The glycosaminoglycans have a high negative charge due to their sulfation. Large proteoglycans like versican with numerous chondroitin sulfate chains have an extremely high negative charge and can ionically interact with other molecules. Based on the early embryonic expression of versican and its ability to ionically interact with water, versican is hypothesized to play a role in the spacing of developing muscle fibers (Fernandez et al., 1991) . Although not demonstrated in skeletal muscle, Zhang et al. (1998) reported in NIH 3T3 fibroblast cells that versican plays a role in modulating cell proliferation. The results from the current study in skeletal muscle are consistent with these findings, as the reduction in versican expression was associated with increased cellular proliferation in both the F and RBC2 lines with proliferation being higher in the F line. The expression of versican was also at its highest during the proliferation of the satellite cells. Versican may play an important role in muscle differentiation, as differentiation was decreased in the F line by the versican treatment.
Matrix Gla protein was highly expressed in skeletal muscle tissue at 1 d posthatch relative to the 18-d embryo and 16-wk bird in both the F and RBC2 lines (Sporer et al., 2011b) . There have been no previous publications identifying a role for MGP in skeletal muscle, but MGP is highly expressed by vascular smooth muscle cells (Proudfoot and Shanahan, 2006) . In other tissues, MGP has been shown to be important in intracellular calcium homeostasis (Proudfoot and Shanahan, 2006) . It is expressed in late hypertrophic chondrocytes (Newman et al., 2001 ) and interacts with bone morphogenetic protein (Wallin et al., 2000; Boström et al., 2001; Zebboudj et al., 2002) . Matrix Gla protein was expressed in both the F and RBC2 satellite cells at higher levels during differentiation, but interestingly, the knockdown of MGP affected proliferation of the F line only with decreased proliferation. During differentiation, the effect was late in differentiation at 72 h with differentiation elevated in both the F and RBC2 lines by the knockdown of MGP. However, only the F line had a statistically significant gene effect.
Death-associated protein was highly expressed at the 18-d stage of embryonic development in the F and RBC2 lines and was more highly expressed in the RBC2 line than the F line at 1 d posthatch (Sporer et al., 2011b) . This protein is not well documented in terms of its function in other tissues and has not been previously reported to have a function in skeletal muscle development. Surprisingly, the knockdown of DAP expression reduced multinucleated myotube formation in both the F and RBC2 lines and resulted in rounded cells frequently observed during apoptosis. If multinucleated myotube formation is inhibited, the development of functional contractile muscle will be prevented. These data suggest that DAP plays a critical role in myogenesis, and its expression is required for the development of mature muscle cells.
The mechanisms regulating the functions of each of these proteins and their associated signaling pathways remain to be determined. The G3 domain of versican has been shown to stimulate proliferation in fibroblasts (Zhang et al., 1998 ). In the current study, versican expression, especially in the growth-selected F line, was high during proliferation and then declined with time. Velleman et al. (2000) reported that the F line satellite cell proliferation rate was higher than that of the RBC2 line. Knockdown data suggested that versican is a regulator of proliferation.
For muscle cell differentiation to occur and result in the formation of multinucleated myotubes, muscle cells must migrate and align with each other and then fuse. The reduction in versican and MGP expression affected later stages of the differentiation process in vitro, but multinucleated myotube formation was not inhibited. In contrast, knocking down DAP expression reduced both differentiation and the formation of myotubes in both the RBC2 and F lines.
In a recent study by Koren et al. (2010) on human DAP, DAP was shown to have a role in the autophagy of HeLa cells. Autophagy was increased with DAP knockdown in that study. Koren et al. (2010) found that DAP is a substrate of mTOR and, when mTOR is active, Ser3 and Ser51 of DAP are phosphorylated, leading to a silencing of DAP. Future studies will need to address the regulation of muscle DAP by mTORdependent phosphorylation. Factors such as caloric restriction lead to dephosphorylation of DAP, which in turn stimulates autophagy. It is clear from the current knockdown studies that DAP has a significant effect on the formation of multinucleated myotubes. If multinucleated myotube formation is inhibited, further development into mature muscle fibers will be prevented. Future studies will need to identify the molecular mechanisms by which DAP is involved in skeletal muscle growth and development.
The proliferation and differentiation of muscle cells is dependent on a precise expression of myogenic regulatory factors (Yablonka-Reuveni et al., 2008) , including but not limited to myogenic determination factor 1, myogenic factor 5, myogenin, and myogenic regulatory factor 4. Both myogenic determination factor 1 and myogenic factor 5 expression are necessary for muscle cell proliferation, whereas myogenin and myogenic regulatory factor 4 are requisite for multinucleated myotube and muscle fiber formation, respectively. Myogenic regulatory factor expression being dependent on the expression of other genes is not novel (Cornelison et al., 2001 (Cornelison et al., , 2004 Gutiérrez and Brandan, 2010) . Because the genes in the current study alter muscle development, future research will need to address whether the expression of myogenic regulatory factors is dependent on any of these genes.
Taken together, the findings reported by Sporer et al. (2011b) using the TSKMLO microarray demonstrates that skeletal muscle development involves genes beyond those whose functions are already identified. From this initial study focused on proliferation and differentiation, versican, MGP, and DAP appear to differentially affect these processes. Most striking is DAP, whose underexpression completely prevents myotube formation. Future studies will need to address protein levels, measure apoptosis, and examine signaling pathways affected by each of these genes.
